Dendreon (NYSE: DNDN) was halted at $7.30. DNDN is reporting top-line data from the ongoing Phase 3 IMPACT (Immunotherapy for Prostate AdenoCarcinoma Treatment) this morning. DNDN April 7 straddle is priced at $1.87, May 7 straddle is priced at $6.60 according to Track Data, suggesting large price movement.
NASDAQ 100 (NASDAQ:QQQQ) overall implied volatility at 36; 26-week average is 43. CBOE Volatility Index S&P 500 Options-VIX at 37.81; 10-day moving average is 40.82.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.
Infosys
Closing Bell: When you are just glad the closing bell came (AIG, DELL, GMGMQ, CSCO, POT)
Biotech ETFs: Best bets on health care reform
Cramer on BloggingStocks: The world's been waiting for the new GM 
